Rita Medical To Triple Revenue, U.S. Sales Force With Horizon Merger
This article was originally published in The Gray Sheet
Executive Summary
Rita Medical Systems' $112.4 mil. stock purchase of Horizon Medical Products will appreciably expand the firm's direct sales reach, particularly in rural areas
You may also be interested in...
People In Brief
Rita Medical: Fremont, Calif. company engages executive search firm Stuart Spencer to assist in recruiting new CFO to replace outgoing exec Donald Stewart, who plans to resign as soon as a suitable substitute is found. Stewart served as Rita's interim CEO during 2003 and was a senior member of the firm's integration team during its merger with Horizon Medical Products last year (1"The Gray Sheet" May 17, 2004, p. 21). Rita sells radiofrequency ablation systems using disposable needles under the Starburst brand and vascular access devices including the Vortex ports...
People In Brief
Rita Medical: Fremont, Calif. company engages executive search firm Stuart Spencer to assist in recruiting new CFO to replace outgoing exec Donald Stewart, who plans to resign as soon as a suitable substitute is found. Stewart served as Rita's interim CEO during 2003 and was a senior member of the firm's integration team during its merger with Horizon Medical Products last year (1"The Gray Sheet" May 17, 2004, p. 21). Rita sells radiofrequency ablation systems using disposable needles under the Starburst brand and vascular access devices including the Vortex ports...
Interventional Radiology In Brief
Embolization/RF ablation for liver cancer: Combining minimally-invasive embolization and ablation is as effective as surgery for treating single tumors up to 7 cm in diameter, according to a study abstract presented by Anne Covey, MD, Memorial Sloan Kettering Cancer Center, at the Society of Interventional Radiology annual scientific meeting March 25-30 in Phoenix. Although patients with more advanced liver cancer were treated with the combined treatment, survival rates at one, two, four and five years were 97%, 83%, 77% and 56% compared with 81%, 70%, 70% and 57% for the surgery group. Boston Scientific (Contour SE) and BioSphere Medical (Embosphere Microspheres) are among the firms offering embolization devices, and Boston Scientific (RF 3000), Tyco (Cool-tip) and Rita Medical (Starburst) market RF ablation systems...